In HCC, aldolase B (Aldob) potentiates the p53-mediated inhibition of G6PD through the formation of an Aldob–G6PD–p53 complex, which is independent of Aldob enzymatic activity [53]. Here, ALDOB is linked to hepatocellular carcinoma.